Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting Phase 1 Trials for DB00441 (Gemcitabine)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02495896Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsTreatment